Michael E Saladin
Overview
Explore the profile of Michael E Saladin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
2481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farris S, Rogers A, DiBello A, Altman B, Smith-Caswell J, Lambert-Messerlian G, et al.
Nicotine Tob Res
. 2025 Mar;
PMID: 40036966
Introduction: Estradiol (E2) and progesterone (P) and their fluctuation during the female menstrual cycle have been independently linked to both nicotine reinforcement and anxiety. The fluctuation and withdrawal of E2...
2.
Martin E, Baker N, Ramakrishnan V, Neelon B, Saladin M, McRae-Clark A
Am J Addict
. 2025 Feb;
PMID: 39934545
Background And Objectives: Identifying circumstances associated with cannabis use is critical to the development of effective interventions for cannabis use disorder (CUD) and circumstances may differ by gender. The Inventory...
3.
Ross R, Saladin M, George M, Gregory C
J Psychiatr Res
. 2024 Jun;
176:108-118.
PMID: 38852541
Background: Although complex in nature, the pathophysiology of depression involves reduced or impaired neuroplastic capabilities. Restoring or enhancing neuroplasticity may serve as a treatment target for developing therapies for depression....
4.
Farris S, Smith J, Steinberg D, Altman B, Lambert-Messerlian G, Dunsiger S, et al.
Front Psychiatry
. 2023 Dec;
14:1267753.
PMID: 38076702
Two primary ovarian hormones that fluctuate across the female menstrual cycle-estradiol and progesterone-have been independently linked in separate literatures to nicotine reinforcement and anxiety psychopathology. We identify existing methodological limitations...
5.
Schick M, Baker N, Hood C, Tomko R, Gray K, Ramakrishnan V, et al.
Nicotine Tob Res
. 2023 Jul;
26(3):392-396.
PMID: 37493638
Introduction: Females, versus males, have shown a slower decline in smoking prevalence, greater smoking-related mortality and morbidity, and tend to have more difficulty achieving and maintaining abstinence. Identifying sex-specific risk...
6.
Gex K, Gray K, Davis C, Squeglia L, McRae-Clark A, Saladin M, et al.
Psychol Addict Behav
. 2023 Jul;
37(6):809-822.
PMID: 37471012
Objective: Cannabis use motives and craving are associated with increased risk for cannabis-related problems and are ideal targets for prevention and early intervention. Patterns of motives and craving reactivity to...
7.
Palmer A, Carpenter M, Baker N, Froeliger B, Foster M, Garland E, et al.
Exp Clin Psychopharmacol
. 2023 Mar;
32(1):16-26.
PMID: 36913266
Despite decades of progress, cigarette smoking remains a significant contributor to disease burden. This effect is especially pronounced for specific priority populations, such as individuals who live in rural communities,...
8.
Martin E, Neelon B, Brady K, Guille C, Baker N, Ramakrishnan V, et al.
Am J Drug Alcohol Abuse
. 2023 Mar;
49(2):190-198.
PMID: 36881810
Adverse childhood experiences (ACEs) show a graded association with the development of substance use disorders (SUDs) and engagement in risky substance use behaviors. Women are overrepresented among individuals with more...
9.
Hahn C, Kilimnik C, Brady K, Marx B, Rothbaum B, Saladin M, et al.
Contemp Clin Trials
. 2022 Nov;
125:107002.
PMID: 36436732
The co-occurrence of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) is common following sexual assault and associated with more severe symptomology and increased likelihood of sexual revictimization. Integrated...
10.
Ross R, VanDerwerker C, Saladin M, Gregory C
Mol Psychiatry
. 2022 Oct;
28(1):298-328.
PMID: 36253441
Globally, depression is a leading cause of disability and has remained so for decades. Antidepressant medications have suboptimal outcomes and are too frequently associated with side effects, highlighting the need...